Influence des préférences alimentaires sur la survenue de la dénutrition chez les patients pris en charge pour un carcinome broncho-pulmonaire non à petites cellules de stade IV

Essai clinique

Type : Académique
Statut : Ouvert
Phase : IV
Étape du traitement : Soins de support
Étape de prise en charge : Entretien
Date d'ouverture : 01/11/2022
Date clôture : 01/11/2025
Promoteur : Centre Georges Francois Leclerc
Progression du cancer: Pas de progression
Résumé :

The study will be offered to patients with non-small cell lung carcinoma diagnosed at stage IV and receiving first-line treatment.

The patient will benefit from a complete assessment at inclusion (clinical exam, imagery, biological exam, dietary consultation, test LFQP.

At the end of this 1st evaluation, patients in whom the diagnosis of undernutrition is made will benefit from dietary management with personalized advice that will take into account the symptoms of cancer, the possible side effects of treatments as well as the social environment.

Every two cures, i.e. every 4 to 6 weeks, these examens will be performed until the occurrence of an event (progression of the disease according to the RECIST criteria, death or change of therapeutic line). At the end of these assessments, patients will benefit from dietary management with a readjustment of personalized advice that will take into account the difficulties highlighted during the assessment.

Domaines/spécialités :
  • Cancers thoraciques respiratoires
    • Cancer bronchique non à petites cellules
Pathologies :
  • Tumeur maligne des bronches et du poumon - Cim10 : C34
Liens externes :

Critères de population

Sexe : Homme et femme
Age minimum : 18 ans
Age maximum : 70 ans
Critères d’inclusion :
  • Diagnosis of stage IV non-small cell lung carcinoma with indication for first-line systemic treatment (chemotherapy, immunotherapy or specific treatment, in particular tyrosine kinase inhibitors) according to current French recommendations.
  • Age over 18 and under 70
  • Patient speaking and reading French fluently
  • Affiliation to a social security scheme
  • Patient able and willing to follow all study procedures in accordance with the protocol
  • Patient having understood, signed and dated the consent form
Critères d’exclusion :
  • Patient requiring hospitalization for more than 48 hours for the administration of the first course of treatment
  • Patient benefiting from antibiotic therapy for the treatment of an acute infection
  • Psychiatric, cognitive or neurological disorders making it impossible to assess food preferences and/or any impossibility to undergo medical monitoring for the trial for geographical, social or psychological reasons.
  • Daily alcohol consumption
  • Chest radiotherapy treatment
  • Pregnant woman, likely to be, or breastfeeding
  • Persons deprived of liberty or under guardianship

Centre d'investigation

En cours
Nom : Centre Georges François Leclerc - CGFL
Ville : DIJON (21)
RESPONSABLE MÉDICAL
Nom : Dr FAVIER
Prénom : Laure
Téléphone : Non disponible
Email : lfavier@cgfl.fr
CONTACT TECHNIQUE
Nom : LAPORTE
Prénom : Geneviève
Téléphone : 03 80 73 77 89
Email : glaporte@cgfl.fr

Référentiels Oncologik

Aucun référentiel n'est lié à cet essai.